Golden Throat Holdings Reports 39.1% Revenue Drop to RMB319.2 Million and 37.6% Profit Decline in H1 2025
Golden Throat Holdings Group reported a significant financial decline in the first half of 2025. The company's revenue dropped 39.1% to RMB319.2 million, with gross profit falling 37.1% to RMB246.3 million. Profit attributable to equity holders decreased 37.6% to RMB83.7 million. The Board of Directors did not recommend an interim dividend, reflecting the challenging financial period for the company.
Reuters · 08/28 11:45
GOLDEN THROAT HOLDINGS GROUP H1 NET INCOME RMB 83.7 MILLION
Reuters · 08/28 11:43
Golden Throat Holdings Group Company Limited (HKG:6896) Might Not Be As Mispriced As It Looks After Plunging 25%
Simply Wall St · 08/19 23:27
Golden Throat Holdings Group (HKG:6896) Knows How To Allocate Capital Effectively
Simply Wall St · 08/12 22:03
The recent 14% gain must have brightened CEO Yong Zeng's week, Golden Throat Holdings Group Company Limited's (HKG:6896) most bullish insider
Insider control over Golden Throat Holdings Group, with 62% of shares held by CEO Yong Zeng, suggests vested interests in company growth. The lack of institutional ownership and analyst coverage may indicate limited attention from fund managers. General public ownership stands at 30%, while private companies hold 8%. Insider ownership is viewed positively as it aligns the board with shareholders, but excessive power concentration is a concern. The company's market cap reached HK$3.7 billion following a 14% stock gain. Consideration of various shareholder groups and other factors is recommended for a comprehensive understanding of Golden Throat Holdings Group.
Simply Wall St · 07/21 22:17
Golden Throat Holdings Group's (HKG:6896) five-year total shareholder returns outpace the underlying earnings growth
Simply Wall St · 06/17 23:54
Golden Throat Holdings Group's (HKG:6896) Dividend Will Be Reduced To CN¥0.50
Golden Throat Holdings Group Company Limited (HKG:6896) will pay a dividend of CN¥0.50 on 26th June, down from last year's comparable dividend. The yield is still above the industry average at 9.4%. Despite this, the stock price has increased by 67% in the last 3 months, which may explain the decrease in dividend yield. The company's dividend was higher than its profits, making up 83% of cash flows. Over the next year, EPS could expand by 13.7%, but the payout ratio could be 127%, putting pressure on the balance sheet. Golden Throat Holdings Group's dividend history shows inconsistency, with rapid growth followed by cuts. While earnings per share have grown at 14% per year over the past five years, the high payout ratio may limit future dividend growth. The company does not appear to be a reliable income stock due to its inconsistent dividend policy.
Simply Wall St · 06/02 23:15
Why Investors Shouldn't Be Surprised By Golden Throat Holdings Group Company Limited's (HKG:6896) 25% Share Price Surge
Simply Wall St · 05/29 23:15
We Think Some Shareholders May Hesitate To Increase Golden Throat Holdings Group Company Limited's (HKG:6896) CEO Compensation
Golden Throat Holdings Group will hold its AGM on June 3rd, with CEO Yong Zeng's total pay for the year being CN¥9.2m, which is 593% above the industry average. The company's EPS grew by 19% over three years, and shareholders received a total return of 332%. CEO compensation is not expected to be the main focus at the AGM, but some shareholders may still be cautious. Yong Zeng owns HK$2.4b worth of shares in the company. The CEO's salary is CN¥3.3m, while other compensation makes up 64% of the total. Golden Throat Holdings Group has shown respectable growth, with revenue up 23% last year. Despite this, CEO remuneration might not be the central point of focus at the upcoming AGM, although investors should remain aware of other business performance issues.
Simply Wall St · 05/27 22:13
Golden Throat Holdings Group's (HKG:6896) Shareholders Will Receive A Smaller Dividend Than Last Year
Golden Throat Holdings Group Company Limited (HKG:6896) will pay a dividend of CN¥0.50, down from last year, with an annual payment of 9.8% of the current stock price, above the industry average. The company's stock price has increased by 58% in the last 3 months, which may have contributed to the decrease in dividend yield. Golden Throat Holdings Group's dividend payments have been inconsistent, growing rapidly at times but also decreasing. The company has paid dividends since 2016, with a yearly growth rate of about 28%. However, the high payout ratio may limit future dividend growth. Investors should consider other factors when assessing the company, and the article does not constitute financial advice.
Simply Wall St · 05/15 22:23
We Like The Quality Of Golden Throat Holdings Group's (HKG:6896) Earnings
Simply Wall St · 05/08 23:24
Golden Throat Holdings Group Full Year 2024 Earnings: EPS: CN¥0.43 (vs CN¥0.34 in FY 2023)
Golden Throat Holdings Group shares are up 2.4% from a week ago. Mainland China segment contributed 99% of total revenue in the last 12 months. The largest operating expense was Sales & Marketing costs, amounting to CN¥355.1m. We've discovered 1 warning sign about Golden Throat Holding Group.
Simply Wall St · 04/28 01:12
Golden Throat Holdings Group Company Limited (HKG:6896) Looks Just Right With A 26% Price Jump
Simply Wall St · 04/08 22:42
Golden Throat Holdings Group Full Year 2024 Earnings: EPS: CN¥0.43 (vs CN¥0.34 in FY 2023)
Simply Wall St · 03/31 01:51
GOLDEN THROAT HOLDINGS GROUP FY REVENUE RMB 1,185 MILLION
Reuters · 03/28 13:46
Golden Throat Holdings Group Company Limited's (HKG:6896) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Simply Wall St · 03/20 00:27
Golden Throat Holdings Group First Half 2024 Earnings: EPS: CN¥0.18 (vs CN¥0.17 in 1H 2023)
Golden Throat Holdings Group's share price is broadly unchanged from a week ago. The company has reported strong results for the first half of 2024. However, the company has one warning sign for investors to be aware of. Golden Throat Holdings Group's shares are trading at a discount to the market.
Simply Wall St · 09/29/2024 00:08
About Golden Throat Holdings Group
Golden Throat Holdings Group Co Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical, healthcare food and other products. The Company has three products categories that include Golden Throat Lozenges (Over the Counter), which is designed to relieve symptoms of sore and dry throat and hoarse voice caused by acute pharyngitis, Golden Throat Series Products including Dule Lozenges and others, and other products including Yinxingye Tablet, Golden Throat Intestinal Series and others. The Company mainly conducts its business in the domestic and overseas markets.
More
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.